Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein.

作者: Lan Tian , Donn M. Stewart , David L. Nelson

DOI:

关键词: Wiskott–Aldrich syndrome proteinProfilin bindingGeneticsMotilityCytoskeletonMissense mutationBiologyMutantSignal transductionWiskott–Aldrich syndrome

摘要: Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia, eczema, immune deficiency, and a proclivity toward lymphoid malignancy. Lymphocytes of affected individuals show defects activation, motility, cytoskeletal structure. The disease gene encodes 502-amino acid protein named the WAS (WASP). Studies have identified number important interactions that place WASP in role integrating signaling pathways with function. We performed two-hybrid screen to identify proteins interacting cloned proline-rich as specific interactor. Our clone this protein, termed (WIP) others, shows difference seven amino residues, compared previously published sequence revealing additional profilin binding motif. Deletion mutant analysis reveals residues 101–151 are necessary for WASP-WIP interaction. Point analyses system vitro impairment interaction three missense mutants known cause WAS. conclude impaired may contribute

参考文章(50)
Qili Zhu, Chiaki Watanabe, Ting Liu, Diane Hollenbaugh, R. Michael Blaese, Steven B. Kanner, Alejandro Aruffo, Hans D. Ochs, Wiskott-Aldrich Syndrome/X-Linked Thrombocytopenia: WASP Gene Mutations, Protein Expression, and Phenotype Blood. ,vol. 90, pp. 2680- 2689 ,(1997) , 10.1182/BLOOD.V90.7.2680
P. M. Brickell, S. Banin, C. Kinnon, R. C. Lovering, I. Gout, G. O. C. Cory, R. J. Levinsky, L. Maccarthy-Morrogh, Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. Journal of Immunology. ,vol. 157, pp. 3791- 3795 ,(1996)
Alberto G. Ugazio, Alberto Albertini, Alessandro Borsatti, Raffaele Badolato, Alberto Mantovani, Luigi D. Notarangelo, Maurilia Fiorini, Silvano Sozzani, Fabio Malacarne, Susanna Bresciani, Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. Journal of Immunology. ,vol. 161, pp. 1026- 1033 ,(1998)
E Remold-O'Donnell, C Terhorst, J Sancho, F S Rosen, I J Molina, T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. Journal of Immunology. ,vol. 151, pp. 4383- 4390 ,(1993)
D Kenney, L Cairns, E Remold-O'Donnell, J Peterson, FS Rosen, R Parkman, Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome Blood. ,vol. 68, pp. 1329- 1332 ,(1986) , 10.1182/BLOOD.V68.6.1329.1329
Donald B. Smith, Lynn M. Corcoran, Expression and purification of glutathione-S-transferase fusion proteins. Current protocols in molecular biology. ,vol. 28, ,(1994) , 10.1002/0471142727.MB1607S28
Q Zhu, M Zhang, RM Blaese, JM Derry, A Junker, U Francke, SH Chen, HD Ochs, The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene Blood. ,vol. 86, pp. 3797- 3804 ,(1995) , 10.1182/BLOOD.V86.10.3797.BLOODJOURNAL86103797
Bundy Bm, Strober W, Pitchon He, Nelson Dl, Blaese Rm, The Effector Cells in Human Peripheral Blood Mediating Mitogen-Induced Cellular Cytotoxicity and Antibody-Dependent Cellular Cytotoxicity Journal of Immunology. ,vol. 117, pp. 1472- 1481 ,(1976)